Bubble Intelligence

Market Intelligence For The New Regime

Merck & Co., Inc.
MRK
Latest Filing: May 4, 2026 • 24 Total Filings
Total Assets
2026
$128.69B
Total Revenue
2026
$16.29B
Net Income
2026
$-4.24B
Operating Cash Flow
2026
$3.92B
Filing Year:
2025
Only 2025 data available
Data Source:
Showing data from all document types
Filters:
competes withcompetes with
Merck & Co., Inc.
Ticker: MRK
Unknown Region
1 supplier
AstraZeneca
Collaboration partner, not a competitor in this context
AstraZeneca PLC
React Flow
Legend:
Company
Critical Supplier
Significant Supplier
Standard Supplier
Major Competitor
Emerging Competitor
Competitor